IDiyas

For the Inventor, By the Inventor

Toyonaka, Japan

Yousuke Katsura

USPTO Granted Patents = 11

Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 45(Granted Patents)


Location History:

  • Uenonishi, JP (1985 - 1988)
  • Toyonaka, JP (1991 - 1996)

Company Filing History:

goldMedal11 out of 940 
 
Fujisawa Pharmaceutical Company, Ltd.
 patents

Years Active: 1985-1996

Loading Chart...
11 patents (USPTO):Explore Patents
1. 5532258 - H.sub.2 -receptor antagonist thiazoles (1996-07-02),
2. 5512588 - Furylthiazoles and their use as H.sub.2 - receptor antagonists and (1996-04-30),
3. 5371097 - Thiazole derivatives, processes for the preparation thereof and (1994-12-06),
4. 5364871 - New thiazole derivatives, and pharmaceutical composition comprising the (1994-11-15),
5. 5308857 - Furylthiazole derivatives, processes for the preparation thereof and (1994-05-03),
6. 5047411 - Benzazole compounds and pharmaceutical composition comprising the same (1991-09-10),
7. 4767780 - Benzene-fused heterocyclic compound and their use as diuretics (1988-08-30),
8. 4764514 - Oxothiazolidine compound and composition containing same (1988-08-16),
9. 4692444 - 1,4-Dihydro[1]benzothiopyrano[4,3-c]pyrazole derivatives, compositions (1987-09-08),
10. 4675324 - Substituted pyrazolo [4,3-c]pyridines and their use as uricosuric, (1987-06-23),
11. 4562190 - Benzothiazolone derivatives, processes for preparation thereof and (1985-12-31),

Title: Innovator Spotlight: Yousuke Katsura

Introduction: Yousuke Katsura is a prominent inventor based in Toyonaka, Japan. With a remarkable portfolio of 11 patents, he has made significant contributions to the field of pharmaceutical innovations, particularly in the development of H2-receptor antagonists. His work has had a profound impact on the medical community, especially concerning antiulcer medications.

Latest Patents: Among his latest patents, Yousuke has developed thiazole compounds that exhibit antiulcer activity and H2-receptor antagonism. These compounds feature a formula that allows for variations in the alkyl and alkoxy groups, providing flexibility in their application. One noteworthy invention includes furylthiazoles that are utilized as H2-receptor antagonists, showcasing his expertise and innovative thinking in medicinal chemistry.

Career Highlights: Yousuke Katsura has dedicated his career to advancing pharmaceutical research and development. Currently, he is associated with Fujisawa Pharmaceutical Company, Ltd., where he continues to drive innovation in the field. His work has not only contributed to the understanding of receptor antagonism but has also paved the way for new therapeutic solutions that improve patient outcomes.

Collaborations: Throughout his career, Yousuke has collaborated with other esteemed professionals in the industry, including Hisashi Takasugi and Yoshikazu Inoue. These collaborations have enhanced the development and implementation of his groundbreaking inventions and have fostered a spirit of teamwork and shared knowledge within the pharmaceutical community.

Conclusion: Yousuke Katsura represents the essence of innovation in the pharmaceutical sector. His extensive patent portfolio and successful collaborations underscore his commitment to improving healthcare through his inventions. As he continues his work at Fujisawa Pharmaceutical Company, Ltd., the future of medical advancements looks promising with his contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…